Cryogenic spray, cutaneous
Access comprehensive regulatory information for Cryogenic spray, cutaneous in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Viatris Pty Ltd, manufactured by Oystershell NV in Belgium. The device registration started on August 12, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class IIa
Class IIa
Cryogenic spray, cutaneous
Australia TGA ARTG Registered Device
Good Name: Viatris Pty Ltd - Cryogenic spray, cutaneous
Intended Purpose
A device used to treat warts and verrucas by freezing.
Device Classification
Risk Class
Class IIa
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
August 12, 2019
Effective Date
August 12, 2019
Sponsor
Name
Viatris Pty LtdManufacturer